Yes. Circulating tumor DNA (ctDNA) can detect acquired resistance mutations, often before they appear on imaging, because tumors shed DNA carrying resistance-conferring alterations into the blood. Serial ctDNA testing is used to track the emergence of these mutations during therapy, supporting timely treatment adjustments.
x